Cargando…
RORγt Inhibitor-SR1001 Halts Retinal Inflammation, Capillary Degeneration, and the Progression of Diabetic Retinopathy
Diabetic retinopathy is a diabetes-mediated retinal microvascular disease that is the leading cause of blindness in the working-age population worldwide. Interleukin (IL)-17A is an inflammatory cytokine that has been previously shown to play a pivotal role in the promotion and progression of diabeti...
Autores principales: | Zapadka, Thomas E., Lindstrom, Sarah I., Taylor, Brooklyn E., Lee, Chieh A., Tang, Jie, Taylor, Zakary R. R., Howell, Scott J., Taylor, Patricia R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7279039/ https://www.ncbi.nlm.nih.gov/pubmed/32429598 http://dx.doi.org/10.3390/ijms21103547 |
Ejemplares similares
-
Inhibition of CD40-TRAF6-dependent inflammatory activity halts the onset of diabetic retinopathy in streptozotocin-diabetic mice
por: Howell, Scott J., et al.
Publicado: (2022) -
Anti-IL17A Halts the Onset of Diabetic Retinopathy in Type I and II Diabetic Mice
por: Zhou, Amy Y., et al.
Publicado: (2023) -
IL-17A Enhances Retinal Neovascularization
por: Taylor, Brooklyn E., et al.
Publicado: (2023) -
Aryl Hydrocarbon Receptor Agonist VAF347 Impedes Retinal Pathogenesis in Diabetic Mice
por: Zapadka, Thomas E., et al.
Publicado: (2021) -
Retinal Inflammation, Oxidative Stress, and Vascular Impairment Is Ablated in Diabetic Mice Receiving XMD8-92 Treatment
por: Howell, Scott J., et al.
Publicado: (2021)